Two different risk models for identification of cancer patients at high risk of VTE
| Khorana VTE risk assessment score5 . | Points . | ||
|---|---|---|---|
| Site of cancer | Very high risk | Stomach, pancreas | 2 |
| High risk | Lung, lymphoma, gynecologic, bladder, testicular | 1 | |
| Platelet count | ≥350 × 109/L | 1 | |
| Hemoglobin and/or use of erythropoiesis-stimulating agents | <10 g/dL | 1 | |
| Leukocyte count | >11 × 109/L | 1 | |
| Body mass index | ≥35 kg/m2 | 1 | |
| Vienna VTE risk assessment score,19 addition of | |||
| d-dimer | ≥1.44 μg/mL | 1 | |
| sP-selectin | ≥53.1 mg/mL | 1 | |
| Khorana VTE risk assessment score5 . | Points . | ||
|---|---|---|---|
| Site of cancer | Very high risk | Stomach, pancreas | 2 |
| High risk | Lung, lymphoma, gynecologic, bladder, testicular | 1 | |
| Platelet count | ≥350 × 109/L | 1 | |
| Hemoglobin and/or use of erythropoiesis-stimulating agents | <10 g/dL | 1 | |
| Leukocyte count | >11 × 109/L | 1 | |
| Body mass index | ≥35 kg/m2 | 1 | |
| Vienna VTE risk assessment score,19 addition of | |||
| d-dimer | ≥1.44 μg/mL | 1 | |
| sP-selectin | ≥53.1 mg/mL | 1 | |
In the CATS, brain tumors (high-grade glioma) were allocated to the very high risk sites of cancer.